Concepts (150)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Models, Statistical | 1 | 2010 | 20 | 0.340 |
Why?
|
| Humans | 13 | 2016 | 1883 | 0.260 |
Why?
|
| Pituitary Apoplexy | 1 | 2005 | 1 | 0.240 |
Why?
|
| Pituitary Neoplasms | 1 | 2005 | 1 | 0.240 |
Why?
|
| Adenoma | 1 | 2005 | 2 | 0.240 |
Why?
|
| Female | 9 | 2016 | 966 | 0.200 |
Why?
|
| Male | 9 | 2016 | 1036 | 0.190 |
Why?
|
| Neovascularization, Pathologic | 2 | 2015 | 2 | 0.190 |
Why?
|
| Aged | 7 | 2014 | 414 | 0.180 |
Why?
|
| Adult | 6 | 2016 | 549 | 0.160 |
Why?
|
| Middle Aged | 6 | 2014 | 488 | 0.160 |
Why?
|
| Retrospective Studies | 4 | 2016 | 102 | 0.140 |
Why?
|
| Pancreatic Neoplasms | 2 | 2015 | 3 | 0.130 |
Why?
|
| Cryosurgery | 2 | 2013 | 2 | 0.130 |
Why?
|
| Evoked Potentials, Somatosensory | 1 | 2016 | 1 | 0.130 |
Why?
|
| Scoliosis | 1 | 2016 | 2 | 0.130 |
Why?
|
| Monitoring, Intraoperative | 1 | 2016 | 4 | 0.130 |
Why?
|
| Spinal Fusion | 1 | 2016 | 10 | 0.130 |
Why?
|
| Phagocytosis | 1 | 2015 | 3 | 0.110 |
Why?
|
| Blood Platelets | 1 | 2015 | 17 | 0.110 |
Why?
|
| Endothelial Cells | 1 | 2015 | 6 | 0.110 |
Why?
|
| Signal Transduction | 1 | 2015 | 71 | 0.110 |
Why?
|
| Combined Modality Therapy | 3 | 2013 | 19 | 0.110 |
Why?
|
| Dietary Proteins | 1 | 2014 | 1 | 0.110 |
Why?
|
| Muscles | 1 | 2014 | 39 | 0.100 |
Why?
|
| Treatment Outcome | 3 | 2013 | 118 | 0.100 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2013 | 2 | 0.100 |
Why?
|
| Liver Neoplasms | 1 | 2013 | 4 | 0.100 |
Why?
|
| Dendritic Cells | 1 | 2013 | 4 | 0.100 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2013 | 2 | 0.100 |
Why?
|
| Brachytherapy | 1 | 2012 | 1 | 0.100 |
Why?
|
| Iodine Radioisotopes | 1 | 2012 | 2 | 0.100 |
Why?
|
| Glaucoma | 1 | 2012 | 1 | 0.090 |
Why?
|
| Nerve Fibers | 1 | 2012 | 1 | 0.090 |
Why?
|
| Optic Disk | 1 | 2012 | 1 | 0.090 |
Why?
|
| Optic Nerve Diseases | 1 | 2012 | 1 | 0.090 |
Why?
|
| Retinal Ganglion Cells | 1 | 2012 | 1 | 0.090 |
Why?
|
| Tomography, Optical Coherence | 1 | 2012 | 2 | 0.090 |
Why?
|
| Algorithms | 1 | 2012 | 42 | 0.090 |
Why?
|
| Furans | 1 | 2011 | 1 | 0.090 |
Why?
|
| Gram-Positive Bacteria | 1 | 2011 | 1 | 0.090 |
Why?
|
| Tyrosine-tRNA Ligase | 1 | 2011 | 1 | 0.090 |
Why?
|
| Adolescent | 2 | 2016 | 184 | 0.090 |
Why?
|
| Anti-Bacterial Agents | 1 | 2011 | 42 | 0.080 |
Why?
|
| Scleroderma, Systemic | 1 | 2010 | 1 | 0.080 |
Why?
|
| Uterine Cervical Dysplasia | 1 | 2010 | 1 | 0.080 |
Why?
|
| Double-Blind Method | 1 | 2010 | 37 | 0.080 |
Why?
|
| DNA Methylation | 1 | 2010 | 22 | 0.080 |
Why?
|
| Cerebral Arteries | 1 | 2009 | 2 | 0.080 |
Why?
|
| ras Proteins | 1 | 2009 | 1 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2009 | 1 | 0.080 |
Why?
|
| ErbB Receptors | 1 | 2009 | 3 | 0.080 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2009 | 9 | 0.070 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2009 | 18 | 0.070 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2009 | 7 | 0.070 |
Why?
|
| Aged, 80 and over | 4 | 2012 | 209 | 0.070 |
Why?
|
| Lung Neoplasms | 1 | 2009 | 17 | 0.070 |
Why?
|
| Mutation | 1 | 2009 | 63 | 0.070 |
Why?
|
| Alzheimer Disease | 1 | 2009 | 80 | 0.070 |
Why?
|
| Brain | 1 | 2009 | 92 | 0.070 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2006 | 3 | 0.060 |
Why?
|
| Substantia Nigra | 1 | 2006 | 8 | 0.060 |
Why?
|
| Neurofibrillary Tangles | 1 | 2006 | 7 | 0.060 |
Why?
|
| Hormone Replacement Therapy | 1 | 2005 | 1 | 0.060 |
Why?
|
| Hypophysectomy | 1 | 2005 | 2 | 0.060 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2005 | 59 | 0.060 |
Why?
|
| Aging | 1 | 2006 | 75 | 0.060 |
Why?
|
| Coculture Techniques | 2 | 2015 | 5 | 0.050 |
Why?
|
| Sensitivity and Specificity | 2 | 2016 | 48 | 0.050 |
Why?
|
| Immunohistochemistry | 2 | 2015 | 18 | 0.050 |
Why?
|
| Disease Progression | 2 | 2012 | 43 | 0.040 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2010 | 3 | 0.040 |
Why?
|
| Spinal Cord | 1 | 2016 | 7 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2016 | 80 | 0.030 |
Why?
|
| Young Adult | 1 | 2016 | 139 | 0.030 |
Why?
|
| Child | 1 | 2016 | 154 | 0.030 |
Why?
|
| Umbilical Veins | 1 | 2015 | 1 | 0.030 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2015 | 1 | 0.030 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2015 | 1 | 0.030 |
Why?
|
| Cell Communication | 1 | 2015 | 5 | 0.030 |
Why?
|
| Cell Survival | 1 | 2015 | 13 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2015 | 7 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2015 | 19 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2015 | 7 | 0.030 |
Why?
|
| Apoptosis | 1 | 2015 | 24 | 0.030 |
Why?
|
| Mice | 1 | 2015 | 208 | 0.030 |
Why?
|
| Malaysia | 1 | 2014 | 1 | 0.030 |
Why?
|
| India | 1 | 2014 | 2 | 0.030 |
Why?
|
| Arm | 1 | 2014 | 2 | 0.030 |
Why?
|
| Nutrition Assessment | 1 | 2014 | 4 | 0.030 |
Why?
|
| China | 1 | 2014 | 6 | 0.030 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2014 | 3 | 0.030 |
Why?
|
| Anthropometry | 1 | 2014 | 7 | 0.030 |
Why?
|
| Body Weight | 1 | 2014 | 13 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2014 | 35 | 0.030 |
Why?
|
| Killer Cells, Natural | 1 | 2013 | 3 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2013 | 8 | 0.030 |
Why?
|
| Cytokines | 1 | 2013 | 18 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2013 | 88 | 0.030 |
Why?
|
| Postoperative Period | 1 | 2012 | 4 | 0.020 |
Why?
|
| Palliative Care | 1 | 2012 | 2 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2012 | 4 | 0.020 |
Why?
|
| Time Factors | 1 | 2013 | 143 | 0.020 |
Why?
|
| Animals | 1 | 2015 | 728 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2012 | 5 | 0.020 |
Why?
|
| ROC Curve | 1 | 2012 | 12 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 2011 | 3 | 0.020 |
Why?
|
| Gram-Positive Bacterial Infections | 1 | 2011 | 2 | 0.020 |
Why?
|
| Staphylococcus aureus | 1 | 2011 | 3 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2011 | 12 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2011 | 26 | 0.020 |
Why?
|
| Staphylococcal Infections | 1 | 2011 | 7 | 0.020 |
Why?
|
| Sulfotransferases | 1 | 2010 | 1 | 0.020 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2010 | 1 | 0.020 |
Why?
|
| Paired Box Transcription Factors | 1 | 2010 | 1 | 0.020 |
Why?
|
| Cyclin A1 | 1 | 2010 | 1 | 0.020 |
Why?
|
| Death-Associated Protein Kinases | 1 | 2010 | 1 | 0.020 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2010 | 4 | 0.020 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2010 | 10 | 0.020 |
Why?
|
| Logistic Models | 1 | 2010 | 27 | 0.020 |
Why?
|
| Glycoproteins | 1 | 2010 | 13 | 0.020 |
Why?
|
| Risk Factors | 1 | 2010 | 140 | 0.020 |
Why?
|
| Arterioles | 1 | 2009 | 1 | 0.020 |
Why?
|
| Integrin alphaVbeta3 | 1 | 2009 | 1 | 0.020 |
Why?
|
| Gliosis | 1 | 2009 | 2 | 0.020 |
Why?
|
| Cell Count | 1 | 2009 | 3 | 0.020 |
Why?
|
| Microcirculation | 1 | 2009 | 3 | 0.020 |
Why?
|
| Encephalitis | 1 | 2009 | 3 | 0.020 |
Why?
|
| Microglia | 1 | 2009 | 6 | 0.020 |
Why?
|
| Blood-Brain Barrier | 1 | 2009 | 6 | 0.020 |
Why?
|
| Amyloid beta-Peptides | 1 | 2009 | 10 | 0.020 |
Why?
|
| Brain Mapping | 1 | 2009 | 18 | 0.020 |
Why?
|
| DNA, Neoplasm | 1 | 2009 | 1 | 0.020 |
Why?
|
| Gene Amplification | 1 | 2009 | 1 | 0.020 |
Why?
|
| Carcinoma, Adenosquamous | 1 | 2009 | 1 | 0.020 |
Why?
|
| Carcinoma, Large Cell | 1 | 2009 | 1 | 0.020 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2009 | 2 | 0.020 |
Why?
|
| Base Sequence | 1 | 2009 | 17 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2009 | 11 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2009 | 22 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2009 | 10 | 0.020 |
Why?
|
| Biopsy | 1 | 2009 | 11 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2009 | 6 | 0.020 |
Why?
|
| Survival Rate | 1 | 2009 | 9 | 0.020 |
Why?
|
| Adenocarcinoma | 1 | 2009 | 3 | 0.020 |
Why?
|
| Prognosis | 1 | 2009 | 28 | 0.020 |
Why?
|
| Biomarkers | 1 | 2009 | 51 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2006 | 9 | 0.020 |
Why?
|
| Dementia | 1 | 2006 | 31 | 0.010 |
Why?
|
| Parkinson Disease | 1 | 2006 | 42 | 0.010 |
Why?
|